Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bertrand O et al. – The VICTORY trial is the first cardiometabolic study to evaluate the antiatherosclerotic and metabolic effects of rosiglitazone in post–CABG patients with type 2 diabetes.

Related Articles

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 84%

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09    Relevance Score: 83%

Debating cancer and diabetes in Vienna
Practice Nursing, 11/10/09    Relevance Score: 83%

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09    Relevance Score: 83%

A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09    Relevance Score: 83%

Today in Atherosclerosis/Lipids...keeping you current

Lifestyle counselling in primary care: Long-term effects on cholesterol level
The European Journal of General Practice, 12/08/09

Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease
Nutrition, Metabolism & Cardiovascular Diseases, 12/08/09

Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials
Nutrition, Metabolism & Cardiovascular Diseases, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address